News | Peripheral Artery Disease (PAD) | December 29, 2017

Oceanus 14 Pro PTA Balloon Catheter Receives CE Mark Approval

Device approved to dilate stenoses in femoral, popliteal and infrapopliteal arteries

December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (PTA) balloon catheter following CE Mark approval. The device was approved to dilate stenoses in femoral, popliteal and infrapopliteal arteries, and to treat obstructive lesions in arteriovenous dialysis fistulae.

Oceanus 14 Pro features what the company calls an exceptional crossing profile and size range, including ultra-small diameters (1.25mm and 1.5mm) and lengths (10mm and 15mm). It is the only PTA catheter that adapts its number and type of radiopaque markers for enhanced visibility, flexibility and trackability:

  • One tungsten radiopaque marker for the smallest and shortest balloons;
  • Two tungsten radiopaque markers for smaller diameters and lengths over 20mm; and
  • Two metallic radiopaque markers for other references.

For more information: www.ivascular.global


Related Content

News | Peripheral Artery Disease (PAD)

Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...

Home September 12, 2025
Home
News | Peripheral Artery Disease (PAD)

June 6, 2025 – A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 ...

Home June 06, 2025
Home
News | Peripheral Artery Disease (PAD)

Feb. 3, 2025 — Today, Peripheral Artery Disease (PAD) affects 10 million Americans and is the most common cause of limb ...

Home February 04, 2025
Home
News | Peripheral Artery Disease (PAD)

Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD) ...

Home January 13, 2025
Home
News | Peripheral Artery Disease (PAD)

A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more ...

Home January 13, 2025
Home
News | Peripheral Artery Disease (PAD)

Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...

Home December 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with ...

Home December 03, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...

Home September 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...

Home September 04, 2024
Home
Subscribe Now